AXON director buys 1,358 shares at $740; ownership rises to 237,938
Insider purchase reported: Axon Enterprise director Hadi Partovi acquired 1,358 shares of Axon common stock on 08/13/2025 at a weighted average price of $739.9998 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Insider purchase reported: Axon Enterprise director Hadi Partovi acquired 1,358 shares of Axon common stock on 08/13/2025 at a weighted average price of $739.9998 per share. After the purchase, Partovi beneficially owns 237,938 shares. The filing notes the trade was executed in multiple trades with prices ranging from $739.81 to $740.00 and that the reported price reflects a weighted average. The Form 4 was submitted by one reporting person and signed by an attorney-in-fact.
Positive
- Director purchase disclosed: Hadi Partovi acquired 1,358 shares, showing insider buying activity.
- Weighted-average price provided: Filing discloses execution price range ($739.81 to $740.00) and weighted average ($739.9998).
- Post-transaction ownership reported: Beneficial ownership after the transaction is 237,938 shares.
Negative
- No derivative securities reported: Table II shows no derivative positions disclosed on this Form 4.
Insights
TL;DR: A director purchased additional shares, modestly increasing his stake to 237,938 shares; transaction appears routine.
The reported acquisition of 1,358 shares at a weighted average price of $739.9998 is a straightforward open-market purchase by a director. The filing discloses the trade was executed in multiple trades with prices between $739.81 and $740.00. The post-transaction beneficial ownership is 237,938 shares, which provides a clear snapshot of the director's current position. There are no derivative positions disclosed on this Form 4.
TL;DR: Director purchase disclosed cleanly; filing shows standard compliance with Section 16 reporting requirements.
The Form 4 indicates compliance with reporting obligations and includes an explanation about weighted-average pricing across multiple trades. The form is filed by one reporting person and executed via attorney-in-fact. No amendments or complex transactions are shown. From a governance perspective, this is a routine disclosure that increases transparency about insider holdings.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 1,358 | $739.9998 | $1.00M |
Footnotes (1)
- F1. The transaction was executed in multiple trades at prices ranging from $739.81 to $740.00. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did AXON director Hadi Partovi report on Form 4?
Does the Form 4 report any derivative securities for AXON by the reporting person?
Was the Form 4 filed jointly or by a single reporting person for AXON?
AI-generated analysis. How Rhea-AI works. Not financial advice.